(Sharecast News) - Acceler8 Ventures revealed on Tuesday that chairman Nigel Rudd had acquired 121,429 ordinary shares in the London-listed life sciences business.
Rudd, who joined Accler8 in August 2023, purchased the shares at an average price of 70p each, for a total price of £85,000.30.

Following the transaction, Rudd...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE